Acute Kidney Injury

TRT System Now Indicated for AKI Patients

FlowMedica, Inc., of Fremont, Calif., announced that it has received clearance for a new labeling indication for its Benephit Infusion Systems, which can now facilitate targeted renal therapy (TRT) in patients who have demonstrated symptoms of or are at risk of developing acute kidney injury (AKI).

Next post in World Literature Review